Cargando…
Nanocarriers surface engineered with cell membranes for cancer targeted chemotherapy
BACKGROUND: Inspired by nature, the biomimetic approach has been incorporated into drug nanocarriers for cancer targeted chemotherapy. The nanocarriers are cloaked in cell membranes, which enables them to incorporate the functions of natural cells. KEY SCIENTIFIC CONCEPTS OF REVIEW: Nanocarriers sur...
Autores principales: | Lei, Wen, Yang, Chen, Wu, Yi, Ru, Guoqing, He, Xianglei, Tong, Xiangmin, Wang, Shibing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781141/ https://www.ncbi.nlm.nih.gov/pubmed/35062958 http://dx.doi.org/10.1186/s12951-022-01251-w |
Ejemplares similares
-
Prognostic implications of cell division cycle protein 45 expression in hepatocellular carcinoma
por: Yang, Chen, et al.
Publicado: (2021) -
The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
por: Hua, Nanni, et al.
Publicado: (2022) -
Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices
por: Yu, Xian-Yan, et al.
Publicado: (2021) -
Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma
por: Liu, Xiaojun, et al.
Publicado: (2019) -
Synergistic antitumor effects of CDK inhibitor SNS-032 and an oncolytic adenovirus co-expressing TRAIL and Smac in pancreatic cancer
por: Ge, Yun, et al.
Publicado: (2017)